Ionis Pharmaceuticals | IONS - Vertriebs- Und Verwaltungskosten





Vertriebs- Und Verwaltungskosten Veränderung Datum
Agios Pharmaceuticals USD 38.46M 4.51M 2026-03
Alnylam Pharmaceuticals USD 282.51M 2.55M 2026-03
Arrowhead Research USD 41.74M 4.28M 2026-03
Astellas Pharma JPY 234.7B 12.92B 2026-03
BioCryst Pharmaceuticals USD 95.78M 12.77M 2025-12
BioMarin Pharmaceutical USD 258.28M 63.92M 2026-03
Celltrion KRW 12.71B 237.27B 2025-12
Cspc Pharmaceutical CNY 1.87B 95.62M 2025-12
Deva Holding AS TRY 462.26M 48.18M 2023-09
Divis Laboratories Ltd INR 3.4B 10M 2025-06
Esperion Therapeutics USD 39.42M 456K 2025-12
Exelixis USD 139.6M 16.58M 2026-03
Halozyme Therapeutics USD 46.29M 18.35M 2026-03
Ionis Pharmaceuticals USD 151M 21M 2026-03
Kangmei Pharma CNY 237.06M 37.35M 2026-03
Knight Therapeutics CAD 35.45M 4.43M 2025-12
Laboratorios Farma EUR 35.32M 2.75M 2025-06
Malin Corporation EUR 1.1M 400K 2024-12
Medical Developments International AUD 2.84M 4.19M 2025-12
Moderna USD 173M 135M 2026-03
Nektar Therapeutics USD 10.17M 10.17M 2025-12
Neuren Pharmaceuticals AUD 3.74M 2.5M 2025-12
Neurocrine Biosciences USD 318.5M 16.7M 2026-03
Novartis USD 3.14B 296M 2026-03
Omeros USD 11.32M 2.48M 2024-09
OPKO Health USD 50.52M 3.28M 2025-12
Organigram Holdings CAD 7.73M 1.13M 2025-12
Ovoca Bio EUR 632K 2.33M 2025-06
Pfizer USD 2.92B 1.16B 2026-03
Pharma Mar EUR 15.31M 2M 2026-03
PTC Therapeutics USD 73.89M 13.31M 2026-03
Qiagen NV USD 153.88M 10.77M 2025-12
Regeneron Pharmaceuticals USD 647.7M 127.3M 2026-03
Roche Holding CHF 7.28B 3.99B 2025-12
Sarepta Therapeutics USD 54.03M 51.35M 2026-03
Sartorius EUR 221.3M 500K 2026-03
Sino Biopharmaceutical CNY 7.54B 2.23B 2025-06
Tilray USD 24.85M 1.7M 2025-09
Ultragenyx Pharmaceutical USD 88M 1000K 2026-03
Vertex Pharmaceuticals USD 493.7M 6.7M 2026-03
Zealand Pharma A/S 91.81M 99.04M 2025-12
Zz Pientze Pharmaceu CNY 214.31M 42.4M 2026-03